Title |
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
|
---|---|
Published in |
British Medical Journal, December 2009
|
DOI | 10.1136/bmj.b5106 |
Pubmed ID | |
Authors |
Tom Jefferson, Mark Jones, Peter Doshi, Chris Del Mar |
Abstract |
To update a 2005 Cochrane review that assessed the effects of neuraminidase inhibitors in preventing or ameliorating the symptoms of influenza, the transmission of influenza, and complications from influenza in healthy adults, and to estimate the frequency of adverse effects. Search strategy An updated search of the Cochrane central register of controlled trials (Cochrane Library 2009, issue 2), which contains the Acute Respiratory Infections Group's specialised register, Medline (1950-Aug 2009), Embase (1980-Aug 2009), and post-marketing pharmacovigilance data and comparative safety cohorts. Selection criteria Randomised placebo controlled studies of neuraminidase inhibitors in otherwise healthy adults exposed to naturally occurring influenza. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6 | 18% |
Spain | 5 | 15% |
Netherlands | 3 | 9% |
Ecuador | 1 | 3% |
Italy | 1 | 3% |
Unknown | 17 | 52% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 26 | 79% |
Practitioners (doctors, other healthcare professionals) | 4 | 12% |
Scientists | 3 | 9% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 9 | 3% |
France | 3 | 1% |
Japan | 3 | 1% |
United States | 2 | <1% |
Spain | 2 | <1% |
Canada | 2 | <1% |
Brazil | 2 | <1% |
Italy | 1 | <1% |
Ecuador | 1 | <1% |
Other | 12 | 4% |
Unknown | 234 | 86% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 50 | 18% |
Other | 37 | 14% |
Student > Master | 26 | 10% |
Student > Bachelor | 25 | 9% |
Professor > Associate Professor | 22 | 8% |
Other | 87 | 32% |
Unknown | 24 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 154 | 57% |
Agricultural and Biological Sciences | 24 | 9% |
Nursing and Health Professions | 8 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 3% |
Biochemistry, Genetics and Molecular Biology | 7 | 3% |
Other | 40 | 15% |
Unknown | 30 | 11% |